HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis ...

Cellular senescence, where cells permanently stop dividing, plays a complex role in liver health. In a recent review article, ...

A soaring public health concern associated with various risk factors, Hepatocellular carcinoma is particularly a chronic liver disease. In order to combat this rise, awareness and preventive ...

Chronic HBV and HCV infections are the leading causes of hepatocellular carcinoma worldwide ... can significantly reduce viral load and slow disease progression. For HCV, the advent of direct ...

Chronic hepatitis C virus (HCV) infection accounts for most cases of hepatocellular carcinoma (HCC) in Japan and is the second major cause in many other countries. Development of HCC takes a ...

Discover how alcohol consumption exacerbates the risk of cirrhosis and hepatocellular carcinoma by promoting hepatitis B ...

Hepatocellular carcinoma ... found in people living with chronic viral hepatitis, heavy alcohol use, or metabolic dysfunction-associated steatotic liver disease. This landmark trial demonstrates ...

Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...

Hepatocellular carcinoma (HCC). HCC is a malignant tumor derived from hepatocytes and frequently occurs in association with chronic liver disease, especially cirrhosis. Liver transplantation for ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

DelveInsight's Hepatocellular Carcinoma Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, January 20, 2025 ...